Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator. [electronic resource]
Producer: 20170106Description: 19534 p. digitalISSN:- 2045-2322
- Adaptive Immunity -- drug effects
- Animals
- Anti-Inflammatory Agents, Non-Steroidal -- pharmacology
- Breast Neoplasms -- drug therapy
- Cell Line, Tumor
- Cytokines -- metabolism
- Disease Models, Animal
- Humans
- Immunologic Factors -- pharmacology
- Immunomodulation -- drug effects
- Inflammation Mediators -- metabolism
- Lymphocyte Depletion
- Macrophages -- drug effects
- Mice
- Neoplasm Metastasis
- Neovascularization, Pathologic
- Sulindac -- pharmacology
- T-Lymphocyte Subsets -- drug effects
- Tumor Burden -- drug effects
- Tumor Microenvironment -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.